1 terminated, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow fluorescence activated cell sorting: new trials by email Literature Review of fluorescence activated cell sorting trials Research Report on fluorescence activated cell sorting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma RFT5-dgA immunotoxin, fluorescence activated cell sorting, immunohistochemistry staining method - Lymphoma | Phase 2 | Terminated | University of Texas Southwestern Medical Center | 1 | 2008-11-07 | 2018-12-14 |
| Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer autologous Epstein-Barr virus-specific cytotoxic T lymphocytes, carboplatin, gemcitabine hydrochloride - Head and Neck Cancer | Phase 2 | Unknown | National Cancer Centre, Singapore | 35 | 2008-07-01 | 2009-06-29 |
Head and Neck Neoplasms (1) · Lymphoma (1) · Lymphoma, T-Cell, Cutaneous (1) · Mycosis Fungoides (1) · Sezary Syndrome (1)
National Cancer Centre, Singapore (1) · University of Texas Southwestern Medical Center (1)
Singapore (1) · United States (1)